Have You Undergone Morcellation Treatment?

» Posted by on Sep 14, 2016 in Medical Injury | 0 comments

On April 17, 2014, the U.S. Food and Drug Administration issued a safety alert that warned doctors from the continued use of power morcellators in laparoscopic surgery. The first to respond to this FDA safety communication notice was Ethicon, the power morcellator manufacturing unit of Johnson & Johnson. Ethicon suspended its national and global promotion, sales and distribution of its highly-engineered power morcellators, the Gynecare X-Tract Tissue Morcellator, the Morcellex Sigma Tissue Morcellator System, and the Gynecare Morcellex Tissue Morcellator; it also recallied from the market and requested doctors and hospitals to return their power morcellators to the giant manufacturing firm.

A morcellator is a medical device used in laparoscopic or minimally invasive, surgeries. It is designed to cut the uterus and other larger tissues into tiny pieces to enable these (pieces) to pass through a tube that is inserted into the body through a 0.5-1cm incision. This device was made available in the early 1990s to enable doctors to perform hysterectomies faster, with lesser blood loss and pain, and with minimum chances of infection. Despite requiring (four) incisions, these tiny surgical wounds made by the device still healed much faster compared to the 5 – 7 inches abdominal cut necessitated in traditional hysterectomy procedures, which took a long time to heal. Since the 1990s the FDA has approved the use of about two dozen laparoscopic power morcellation devices and, unfortunately, despite the safety warning it issued in 2014, many doctors continued to use the device.

Hysterectomy, which is the second most common surgery performed on women (the first is caesarean section), is the surgical procedure that removes the uterus. It is usually required to treat various conditions, including: ovarian cancer; pelvic cancer or cancer of the uterus; uterine fibroids or myomas; pelvic inflammatory diseases; chronic pelvic pains; uncontrollable vaginal bleeding; growth of uterine fibroids or benign tumors in the uterus; uterine prolapse (a condition wherein the womb or the uterus drops halfway from the cervix to the vagina or birth canal); adenomyosis; and, endometriosis.

As explained by a Morcellator lawsuit attorney, morcellators are particularly well-suited to remove certain noncancerous growths during a laparoscopic surgical procedure, as these devices can help break down non-cancerous tumors and tissues into smaller pieces. However, if a patient does have cancerous tumors or growths (specifically, uterine sarcoma, which are almost undetectable), morcellators can spread these cancerous tissues too. As such, the unintended consequences associated with the use of morcellators can be devastating and may include cancer growth, particularly metastatic leiomyosarcoma, uterine cancer, uterine sarcoma, endometrial stromal sarcoma, the abnormal growth of tissue and/or direct harm to healthy tissues.

Lawsuits have already been filed by a number of women already diagnosed with leiomyosarcoma, the most common type of cancer in women who have gone through morcellation treatment. There are many more women who may still not be aware of the possible effects of power morcellators or who may not know what legal steps to pursue to attain justice if ever they too are victims of the cancerous effects of the device. Contacting a morcellator lawsuit attorney immediately to find out their medical condition and for guidance on the best legal option to take will be a wise thing to do.

Submit a Comment

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>